ArticleInflammatory intestinal diseases

Short-Term Clinical and Biochemical Outcomes of IL-23p19 Inhibitors in Refractory Ulcerative Colitis: A Real-World Case Series.

Satohiro Matsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.